Sunitinib malate
Sunitinib (marketed as Sutent, previously known as SU11248) is a small molecule receptor tyrosine kinase inhibitor that is approved for the treatment of gastrointestinal stromal tumor (GIST) and renal cell carcinoma (RCC).

Chemical Name: N -[2-(diethylamino)ethyl]-5-[( Z )-(5-fluoro-1,2- dihydro-2-oxo-3 H -indol-3-ylidine)methyl]-2,4- dimethyl-1 H -pyrrole-3-carboxamide.

CAS No.: [341031-54-7]

Appearance: Pale brown to brown.

Loss on drying:0.5%max.

Assay by HPLC:99%min.